JOHN M. LEONARD - 04 Jan 2023 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
President and CEO, Director
Signature
James Basta, attorney-in-fact
Issuer symbol
NTLA
Transactions as of
04 Jan 2023
Transactions value $
-$248,302
Form type
4
Filing time
06 Jan 2023, 16:32:49 UTC
Previous filing
04 Jan 2023
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale -$248K -6.67K -0.86% $37.21 767K 04 Jan 2023 Direct F1
holding NTLA Common Stock 58.4K 04 Jan 2023 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023.
F2 Shares held by the John M. Leonard 2015 Irrevocable Trust.